Top Story

Combined-modality treatment effective for muscle-invasive bladder cancer

November 25, 2014

Patients with muscle-invasive bladder cancer who underwent bladder-preserving combined-modality therapy experienced disease-specific survival comparable to that typically observed with cystectomy, according to results of a pooled analysis.

Radical cystectomy remains standard treatment for muscle-invasive bladder cancer, yet bladder-preserving treatment strategies have improved due to evolution of radiation therapy, chemotherapy and patient selection, according to background information provided in the study.

Norman E. Breslow, PhD In the Journals

Female survivors of Wilms tumor may be at increased risk for breast cancer

November 13, 2014
Women who survived Wilms tumor, particularly those who underwent chest radiotherapy, demonstrated increased risk for invasive breast cancer by age 40 years, according to…
In the Journals

Nearly one-third of AYA patients do not receive adequate cancer therapy

November 7, 2014
About 30% of adolescents and young adults with cancer do not receive appropriate initial treatment, according to study results.Arnold L. Potosky, PhD, director of…
Inadequate bladder cancer biopsy linked to increased mortality In the Journals

Inadequate bladder cancer biopsy linked to increased mortality

November 4, 2014
The absence of muscle in the specimen in nearly 50% of all diagnostic resections for bladder cancer was linked to increased mortality, particularly among patients with…
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
CME
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
In the Journals

Combined-modality treatment effective for muscle-invasive bladder cancer

November 25, 2014
Patients with muscle-invasive bladder cancer who underwent bladder-preserving combined-modality therapy experienced disease-specific survival…
Norman E. Breslow, PhD In the Journals

Female survivors of Wilms tumor may be at increased risk for breast cancer

November 13, 2014
Women who survived Wilms tumor, particularly those who underwent chest radiotherapy, demonstrated increased risk for invasive breast cancer by age 40…
In the Journals

Nearly one-third of AYA patients do not receive adequate cancer therapy

November 7, 2014
About 30% of adolescents and young adults with cancer do not receive appropriate initial treatment, according to study results.Arnold L. Potosky
Inadequate bladder cancer biopsy linked to increased mortality In the Journals

Inadequate bladder cancer biopsy linked to increased mortality

November 4, 2014
The absence of muscle in the specimen in nearly 50% of all diagnostic resections for bladder cancer was linked to increased mortality, particularly…
In the Journals

Postsurgical surveillance sufficient for stage I nonseminoma germ cell cancer

October 28, 2014
Most men with stage I nonseminoma germ cell cancer who undergo radical orchiectomy can be followed with surveillance, according to results of a…
Institution Notes

Mount Sinai names vice chairman of urology

October 14, 2014
Ketan Badani, MD, professor of urology at Icahn School of Medicine at Mount Sinai, has been named vice chairman of urology and robotic operations at…
Amit Gupta, MD In the Journals

Radical cystectomy, urinary diversion increased fracture risk among patients with bladder cancer

October 8, 2014
Patients with bladder cancer who underwent radical cystectomy and urinary diversion demonstrated an increased risk for bone fracture, according to…
Jane Walker, MBChB, MSc, PhD, MRCPsych In the JournalsPerspective

Multidisciplinary approach may better detect, treat depression among patients with cancer

HemOnc Today, October 25, 2014
Major depression is common among patients with cancer — particularly those with lung cancer — yet it often goes untreated, according to a series of…
Not again … but I thought the government and Pharma said the problem was fixed? EditorialPublication Exclusive

Not again … but I thought the government and Pharma said the problem was fixed?

HemOnc Today, October 25, 2014
Derek Raghavan, MD, PhD
Bladder cancer is one of the commonest malignancies in Western society.There are more than 75,000 new cases each year in the United States, and about…
Meeting News Coverage

Safety, efficacy of sorafenib exposure inconsistent in HCC, RCC patients

September 29, 2014
There was no apparent relationship between exposure to sorafenib and safety and efficacy among patients with hepatocellular carcinoma or renal cell…
More Headlines »
morganatic-roan
morganatic-roan